Clinical characteristics of patients treating heart failure with and without atrial fibrillation under oral anticoagulant therapy.

被引：0
|
作者：
Roberto Chizzola, P. R. Paulo [1 ]
Issa, V. S. [1 ]
Ayub-Ferreira, S. M. [1 ]
Souza, G. E. C. [1 ]
Salemi, V. C. M. [1 ]
Alves, L. S. [1 ]
Guimaraes, G. V. [1 ]
Bocchi, E. A. [1 ]
机构：
[1] Univ Sao Paulo, Fac Med, Dept Heart Failure, Heart Inst InCor, Sao Paulo, Brazil
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1933
引用
收藏
页码：467 / 467
页数：1
相关论文
共 50 条
  • [1] Risk of osteoporosis in patients with atrial fibrillation with and without oral anticoagulant therapy
    Bezabhe, Woldesellassie M.
    Radford, Jan
    Wimmer, Barbara C.
    Salahudeen, Mohammed S.
    Bindoff, Ivan
    Ling, Tristan
    Peterson, Gregory M.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (08) : 1003 - 1010
  • [2] Pitfall in the anticoagulant therapy in patients with paroxysmal atrial fibrillation and heart failure
    Lin, Yenn-Jiang
    Lin, Chin-Yu
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (10)
  • [3] MODERN ORAL ANTICOAGULANT TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION AND HEART FAILURE: INSIGHTS FROM THE CLINICAL PRACTICE
    Tica, Otilia Anca
    Tica, Ovidiu
    Antal, Liana
    Hatos, Adrian
    Popescu, Mircea Ioachim
    Stoian, Anca Pantea
    Bratu, Ovidiu Gabriel
    Gaman, Mihnea-Alexandru
    Pituru, Silviu Mirel
    Diaconu, Camelia Cristina
    FARMACIA, 2018, 66 (06) : 972 - 976
  • [4] Oral anticoagulant therapy for patients with atrial fibrillation - an update
    Hylek, Elaine M.
    THROMBOSIS RESEARCH, 2008, 123 : S46 - S49
  • [5] Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure
    Savarese, Gianluigi
    Sartipy, Ulrik
    Friberg, Leif
    Dahlstrom, Ulf
    Lund, Lars H.
    HEART, 2018, 104 (13) : 1093 - 1100
  • [6] Clinical determinants of oral anticoagulant therapy in outpatients with heart failure and atrial fibrillation: data from IN-CHF Registry
    Baldasseroni, S
    Fabbri, G
    Marini, M
    Bologna, F
    Gonzini, L
    Naccarella, F
    Vincenzi, A
    Maggioni, AP
    EUROPEAN HEART JOURNAL, 2004, 25 : 452 - 453
  • [7] Atrial fibrillation and heart failure: Factors influencing the choice of oral anticoagulant
    Brown, Louise A. E.
    Boos, Christopher J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 227 : 863 - 868
  • [8] Oral Anticoagulant Agents in Patients With Atrial Fibrillation and Heart Failure Does Heart Failure Status Influence Efficacy and Safety?
    Zannad, Faiez
    Ferreira, Joao Pedro
    JACC-HEART FAILURE, 2016, 4 (11) : 881 - 884
  • [9] Persistence to Oral Anticoagulant Therapy in Japanese Atrial Fibrillation Patients
    Kumamaru, Hiraku
    Matsumoto, Chisa
    Setoguchi, Soko
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 381 - 381
  • [10] The state of oral anticoagulant therapy in patients with atrial fibrillation in Spain
    Ul-Qamar, J. M.
    Kirchhof, P.
    REVISTA CLINICA ESPANOLA, 2015, 215 (02): : 100 - 101
12345